Literature DB >> 7902255

A strategy for characterization of polyethylene glycol-derivatized proteins. A mass spectrometric analysis of the attachment sites in polyethylene glycol-derivatized superoxide dismutase.

M M Vestling1, C M Murphy, D A Keller, C Fenselau, J Dedinas, D L Ladd, M A Olsen.   

Abstract

Base treatment of polyethylene glycol-derivatized superoxide dismutase in which the polyethylene glycol is linked to the protein via a succinyl bridge, removes the polyethylene glycol leaving a succinyl marker. Exhaustive succinylation with d4-succinic anhydride completes the derivatization in order to minimize fractionation in proteolysis, chromatography, and desorption in the mass spectrometer. Production of peptides from the derivatized protein for high resolution and high-resolution tandem MS allows identification of the site that had been derivatized by polyethylene glycol and the determination of the amount of polyethylene glycol originally at each site. The mass spectrometric strategy outlined herein can be applied to other proteins derivatized for therapeutic administration.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902255

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  3 in total

1.  Elucidation of PEGylation site with a combined approach of in-source fragmentation and CID MS/MS.

Authors:  Xiaojun Lu; P Clayton Gough; Michael R DeFelippis; Lihua Huang
Journal:  J Am Soc Mass Spectrom       Date:  2010-01-25       Impact factor: 3.109

2.  Fingerprinting proteins coupled with polymers by mass spectrometry: Investigation of polyethylene glycol-conjugated superoxide dismutase.

Authors:  S K Chowdhury; M Doleman; D Johnston
Journal:  J Am Soc Mass Spectrom       Date:  1995-06       Impact factor: 3.109

3.  Toward top-down determination of PEGylation site using MALDI in-source decay MS analysis.

Authors:  Chul Yoo; Detlev Suckau; Volker Sauerland; Michael Ronk; Minhui Ma
Journal:  J Am Soc Mass Spectrom       Date:  2008-11-01       Impact factor: 3.109

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.